MedPath

Cell Based Non Invasive Prenatal Testing as an Alternative to Chorionic Villus Sampling Following Preimplantation Genetic Testing

Not Applicable
Completed
Conditions
Preimplantation Genetic Diagnosis
Prenatal Diagnoses
Interventions
Procedure: Cell-based non-invasive prenatal testing
Registration Number
NCT04584047
Lead Sponsor
Aalborg University Hospital
Brief Summary

The study aims to investigate whether cell-based non-invasive prenatal testing (cbNIPT) can be used as an alternative to invasive chorionic villus sampling (CVS) in patients who achieve pregnancy following preimplantation genetic testing for monogenic disorders (PGT-M).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
8
Inclusion Criteria
  • Achieved pregnancy following preimplantation genetic testing
Exclusion Criteria
  • None

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Intervention groupCell-based non-invasive prenatal testingThis arm has blood collected either at the time of CVS.
Primary Outcome Measures
NameTimeMethod
Agreement between cbNIPT and CVS (The gold standard)Immidiately after the results from cbNIPT and CVS has been obtained

How do the cbNIPT results compare to the results of the genetic test following CVS

Secondary Outcome Measures
NameTimeMethod
Effectiveness of fetal cell isolationImmidiately after genetic testing of the isolated fetal cells

How large a fraction of the potential fetal cells isolated is verified by genetic testing to be of fetal origin.

Effectiveness of testing the genetic variant of interestImmidiately after genetic testing of the isolated fetal cells

How often does the test on a fetal cell yield a result that allows determination of the mutational status of the embryo with respect to the genetic variant of interest.

Trial Locations

Locations (1)

Fertility Unit, Aalborg University Hospital

🇩🇰

Aalborg, Denmark

© Copyright 2025. All Rights Reserved by MedPath